Efficacy and Safety Study of Apremilast (CC-10004) in Subjects with Moderate-to-Severe Plaque-Type Psoriasis (PSOR-005) and Two Extension Studies (PSOR-005E & PSOR-005LTE)

Sponsor ID

CC-10004-PSOR-005-E-LTE

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 2

Product

Otezla

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.